Home Casteddu.com FAQ My Amedeo About Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Ovarian Neoplasms

  Free Subscription


Articles published in Cancer Chemother Pharmacol

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    April 2009
  1. DEL BENE F , Germani M, De Nicolao G, Magni P, et al
    A model-based approach to the in vitro evaluation of anticancer activity.
    Cancer Chemother Pharmacol. 2009;63:827-36.
    PubMed     Related articles    Abstract available


  2. STOEGER SM , Cowan KH
    Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines.
    Cancer Chemother Pharmacol. 2009;63:807-18.
    PubMed     Related articles    Abstract available


    March 2009
  3. PISANO C , Morabito A, Sorio R, Breda E, et al
    A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.
    Cancer Chemother Pharmacol. 2009.
    PubMed     Related articles    Abstract available


  4. YADAV S , van Vlerken LE, Little SR, Amiji MM, et al
    Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.
    Cancer Chemother Pharmacol. 2009;63:711-22.
    PubMed     Related articles    Abstract available


    February 2009
  5. MITAMURA T , Hosaka M, Takeda M, Watari H, et al
    Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report.
    Cancer Chemother Pharmacol. 2009.
    PubMed     Related articles    Abstract available


    January 2009
  6. SEHOULI J , Camara O, Schmidt M, Mahner S, et al
    Pegylated liposomal doxorubicin (CAELYX((R))) in patients with advanced ovarian cancer: results of a German multicenter observational study.
    Cancer Chemother Pharmacol. 2009.
    PubMed     Related articles    Abstract available


    November 2008
  7. MAENPAA J , Leminen A
    Biweekly docetaxel in recurrent ovarian cancer: a phase I dose finding study.
    Cancer Chemother Pharmacol. 2008.
    PubMed     Related articles    Abstract available


    October 2008
  8. HEIJNS JB , van der Burg ME, van Gelder T, Fieren MW, et al
    Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.
    Cancer Chemother Pharmacol. 2008;62:841-7.
    PubMed     Related articles    Abstract available


    September 2008
  9. LIU H , Liang SL, Kumar S, Weyman CM, et al
    Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression.
    Cancer Chemother Pharmacol. 2008.
    PubMed     Related articles    Abstract available


    August 2008
  10. TARAN A , Ignatov A, Smith B, Costa SD, et al
    Acute hepatic failure following monotherapy with sunitinib for ovarian cancer.
    Cancer Chemother Pharmacol. 2008.
    PubMed     Related articles   


  11. ZAMBONI WC , Strychor S, Joseph E, Parise RA, et al
    Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts.
    Cancer Chemother Pharmacol. 2008;62:417-26.
    PubMed     Related articles    Abstract available


    July 2008
  12. BROWN DP , Chin-Sinex H, Nie B, Mendonca MS, et al
    Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer.
    Cancer Chemother Pharmacol. 2008;.
    PubMed     Related articles    Abstract available


    June 2008
  13. DUAN Z , Ames RY, Ryan M, Hornicek FJ, et al
    CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.
    Cancer Chemother Pharmacol. 2008;.
    PubMed     Related articles    Abstract available


    May 2008
  14. CAMCI C , Sevinc A, Aslan Y, Kalender ME, et al
    Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.
    Cancer Chemother Pharmacol. 2008;.
    PubMed     Related articles    Abstract available


  15. CHEN J , Adikari M, Pallai R, Parekh HK, et al
    Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.
    Cancer Chemother Pharmacol. 2008;61:979-87.
    PubMed     Related articles    Abstract available


    January 2008
  16. JI C , Cao C, Lu S, Kivlin R, et al
    Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells.
    Cancer Chemother Pharmacol. 2008;.
    PubMed     Related articles    Abstract available


  17. BANERJI U , Sain N, Sharp SY, Valenti M, et al
    An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.
    Cancer Chemother Pharmacol. 2008;.
    PubMed     Related articles    Abstract available


    October 2007
  18. KOENSGEN D , Stengel D, Belau A, Klare P, et al
    Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available


    September 2007
  19. SMITH JA , Gaikwad A, Yu J, Wolf JK, et al
    In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected anticancer agents in a panel of human ovarian cancer cell lines.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available


    May 2007
  20. ROYER B , Delroeux D, Guardiola E, Combe M, et al
    Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available


  21. VARMA R , Hector S, Greco WR, Clark K, et al
    Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells.
    Cancer Chemother Pharmacol. 2007;59:711-23.
    PubMed     Related articles    Abstract available


    April 2007
  22. FERRANDINA G , Legge F, Mey V, Nannizzi S, et al
    A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge.
    Cancer Chemother Pharmacol. 2007;.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: